Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register-Based Cohort Study

Risk of cardiovascular disease (CVD) in patients with classical Hodgkin lymphoma (cHL) undergoing contemporary treatment is unclear. cHL patients ≥ 18 years at diagnosis treated with doxorubicin-containing chemotherapy between 2000 and 2022 were matched 1:5 with comparators on birth year, sex, and C...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of haematology 2024-11
Hauptverfasser:	Godtfredsen, Sissel J, Yonis, Harman, Baech, Joachim, Al-Hussainy, Nour R, Riddersholm, Signe, Kober, Lars, Schou, Morten, Christensen, Jacob Haaber, Hutchings, Martin, Dahl-Sørensen, Rasmus Bo, Kamper, Peter, Dietrich, Caroline E, Andersen, Mikkel Porsborg, Torp-Pedersen, Christian, Sogaard, Peter, El-Galaly, Tarec Christoffer, Kragholm, Kristian H
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!